Axelopran

Unknown Manufacturer

Axelopran has been used in trials studying the treatment of OIC and Opioid-induced Constipation.

Overview

Axelopran has been used in trials studying the treatment of OIC and Opioid-induced Constipation.

Technical identifiers

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

METHODS OF TREATING CANCER AND OTHER CONDITIONS WITH A MU OPIOID RECEPTOR ANTAGONIST
EP 4489866 A4Applicant: GLYCYX MOR INCPriority: 2022
CN
EP
US
WO
4 publications
Combination dosage form of a mu opioid receptor antagonist and an opioid agent
US 10369142 B2Applicant: THERAVANCE BIOPHARMA R&D IP LLCPriority: 2015
CN
US
4 publications